Neuroprotective Mechanisms of the ACE2–Angiotensin-(1-7)–Mas Axis in Stroke
- 27 January 2015
- journal article
- research article
- Published by Springer Nature in Current Hypertension Reports
- Vol. 17 (2) , 1-10
Abstract
The discovery of beneficial neuroprotective effects of the angiotensin converting enzyme 2–angiotensin-(1-7)–Mas axis [ACE2–Ang-(1-7)–Mas] in ischemic and hemorrhagic stroke has spurred interest in a more complete characterization of its mechanisms of action. Here, we summarize findings that describe the protective role of the ACE2–Ang-(1-7)–Mas axis in stroke, along with a focused discussion on the potential mechanisms of neuroprotective effects of Ang-(1-7) in stroke. The latter incorporates evidence describing the actions of Ang-(1-7) to counter the deleterious effects of angiotensin II (AngII) via its type 1 receptor, including anti-inflammatory, anti-oxidant, vasodilatory, and angiogenic effects, and the role of altered kinase–phosphatase signaling. Interactions of Mas with other receptors, including bradykinin receptors and AngII type 2 receptors are also considered. A more complete understanding of the mechanisms of action of Ang-(1-7) to elicit neuroprotection will serve as an essential step toward research into potential targeted therapeutics in the clinical setting.Keywords
This publication has 105 references indexed in Scilit:
- Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivoExperimental & Translational Stroke Medicine, 2012
- Differential Mechanisms of Ang (1-7)-Mediated Vasodepressor Effect in Adult and Aged Candesartan-Treated RatsInternational Journal of Hypertension, 2011
- Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic strokeExperimental Physiology, 2011
- ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of goodAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Angiotensin II sustains brain inflammation in mice via TGF-βJournal of Clinical Investigation, 2010
- Candesartan pretreatment is cerebroprotective in a rat model of endothelin‐1‐induced middle cerebral artery occlusionExperimental Physiology, 2009
- Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2009
- MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptidesAmerican Journal of Physiology-Cell Physiology, 2008
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008